Educational information, not medical advice — ask your doctor or midwife.
Copaiba resin is a natural oleoresin harvested by tapping the trunks of Copaifera trees native to the Amazon Basin and tropical South America. Indigenous Amazonian peoples have used it medicinally for at least 500 years, applying it to wounds, skin infections, respiratory complaints, and pain. Unlike many botanicals that contain a single dominant compound, copaiba resin is rich in both volatile sesquiterpenes and diterpenic acids that work together to produce its documented effects.
Copaiba's most studied active compound, beta-caryophyllene (BCP), directly activates CB2 cannabinoid receptors throughout the body — the same receptors targeted by CBD, but without any psychoactive effect. This CB2 activation is the main driver behind copaiba's ability to dial down inflammatory signaling, ease pain, and support immune balance. The diterpenic acids, particularly kaurenoic acid and copalic acid, add additional antimicrobial and tissue-protective effects.
Copaiba essential oil (steam-distilled) is high in BCP and sesquiterpenes but loses most of the diterpenic acids — good for aromatherapy and topical blends. Crude oleoresin capsules or softgels retain both the volatile terpenes and the heavier resin acids, making them the preferred form for internal anti-inflammatory and antimicrobial use. Topical creams and salves are effective for skin and joint applications. Tinctures vary widely in standardization, so product quality checks are important.
Copaiba resin appears in European records as early as 1625, when Portuguese missionaries documented its widespread use by Amazonian tribes for wound care, gonorrhea, bladder infections, and respiratory disease. It entered European pharmacopoeias in the 17th–19th centuries and was listed in the United States Pharmacopoeia from 1820 to 1910 as a treatment for bronchitis and urinary tract infections before falling out of formal medical use. Interest has resurged sharply since the discovery of BCP's CB2 receptor activity in 2008.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.